AI Custom Solutions
Custom pathology AI built around your data, governance, and IT strategy
Service · HybridCompany source
Company profile
About Gestalt Diagnostics
Gestalt Diagnostics is a digital pathology and healthcare IT company that empowers pathologists and healthcare organizations to deliver faster, more accurate diagnoses through integrated technology solutions. The company's flagship PathFlow platform unifies image, case, and patient management in a single automated environment, enabling pathologists to work more efficiently, collaboratively, and at scale. PathCloud provides secure, web-based image sharing and collaboration capabilities for organizations adopting digital pathology without heavy infrastructure requirements. Gestalt's AI Portfolio integrates clinically validated AI applications directly into pathology workflows, enhancing accuracy and efficiency while keeping pathologists in control. The company also offers AI Custom Solutions, allowing organizations to co-develop proprietary AI models aligned to their specific data, workflows, and clinical objectives. Beyond digital pathology, Gestalt provides comprehensive IT services including Health Data Cloud interface engine, Electronic Lab Reporting (ELR), LIS migration, outsourced LIS support, and healthcare IT staff augmentation. Built to the highest compliance standards including HIPAA, SOC 2, and CE-IVD certification, Gestalt serves integrated health networks, academic medical centers, and private laboratories worldwide. The company's solutions are proven to integrate with Epic, Cerner, and all major LIS/EHR systems, supporting clinical pathology workflows, education, and research while helping laboratories modernize, integrate, and scale with confidence.
Company description Gestalt Diagnostics official website
Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Gestalt Diagnostics?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Anatomic pathology
- General pathology subspecialties
Who it serves
- Academic Medical Centers
- Health Systems
- Hospitals
- Laboratories
- Private Labs
Deployment & integration
Cloud Saas · Hybrid · On Premise · Other deployment with recorded integration context.
Recorded integration context: Cerner, Epic, Major LIS systems, Proprietary LIS/EHR systems, Public health reporting agencies.
Geographic context
MarketsWorldwide
Company sourceOfficial website
Company milestones
Platform expansion
Partnership with Leica for integrated hardware and software solution; trusted by integrated health networks and private labs
Partnerships
Recorded partners
- Leica (hardware systems partnership mentioned by BioReference Laboratories)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AI Portfolio
Clinically validated AI applications integrated directly into PathFlow workflow
Software · Cloud SaaSCompany source
ELR (Electronic Lab Reporting)
Automated, compliant laboratory reporting to public health and regulatory agencies
Service · Cloud SaaSCompany source
Health Data Cloud
Secure, web-based interface engine connecting healthcare applications and reporting agencies
Platform · Cloud SaaSCompany source
Healthcare IT Staff Augmentation
Experienced healthcare IT professionals to augment internal teams
Service · OtherCompany source
LIS Migration
End-to-end LIS migrations with minimal downtime and preserved integrations
Service · On PremiseCompany source
Outsourced LIS Support
Expert, ongoing LIS support to maintain system stability and resolve issues quickly
Service · OtherCompany source
PathCloud
Secure, web-based interface for digital image sharing and collaboration
Platform · Cloud SaaSCompany source
PathFlow
Digital pathology platform unifying image, case, and patient management in a single automated environment
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Data set creation for supervised deep learning-based analysis of microscopic images: Review of important considerations and recommendations.Veterinary pathology · Jun 30, 2026
Maintaining and broadening DICOM adoption in digital pathology: A response to "wearing a fur coat in the summertime".Journal of pathology informatics · Nov 1, 2025
Proceedings of the Association for Pathology Informatics Bootcamp 2023: Ethics, equity, and regulations.Journal of pathology informatics · Aug 1, 2025
Information mismatch in PHH3-assisted mitosis annotation leads to interpretation shifts in H&E slide analysis.Scientific reports · Nov 1, 2024
The ACROBAT 2022 challenge: Automatic registration of breast cancer tissue.Medical image analysis · Oct 1, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Faster diagnoses
Accelerates diagnostic workflows and turnaround times
Enhanced diagnostic accuracy
Reduces variability across reads
Improved consistency
Algorithm-supported review enhances accuracy and consistency
Increased throughput
Streamlines reviews and boosts throughput with built-in AI support
BioReference Laboratories
Upgrading and sunsetting legacy pathology platform while implementing innovative digital pathology workflow with AI capabilities
Implemented one of the most innovative workflows in the market with new AI capabilities for digital image analysis
Pathology Diagnostics Services Group
Consolidating cases from different contract hospital and laboratory clients using distinct LIS systems into a single efficient workflow
Successfully consolidated multiple LIS systems into single digital pathology workflow
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Gestalt Diagnostics
Recent articles published on Gestalt Diagnostics's official website.
Digipath Dispatch July ’26
Read on Gestalt DiagnosticsScalability Is the Real Test of AI Maturity
Read on Gestalt DiagnosticsQuality Control Is the Most Undervalued AI Use Case in Pathology
Read on Gestalt DiagnosticsDigital Adoption in Healthcare Is Changing How Systems Are Deployed
Read on Gestalt DiagnosticsThe Most Strategic AI Question Isn’t “Does It Work?” — It’s “Where Should It Sit?”
Read on Gestalt Diagnostics07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pathology & Laboratory Diagnostics
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.